AllianceBernstein’s Calithera Biosciences, Inc CALA Stock Holding History

AllianceBernstein’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,960	Closed	-$192K	–	3491
2021 Q1	$192K	Hold	3,960	–	–	﹤0.01%	3074
2020 Q4	$389K	Hold	3,960	–	–	﹤0.01%	2712
2020 Q3	$273K	Hold	3,960	–	–	﹤0.01%	2854
2020 Q2	$418K	Buy	3,960 +945	+31%	+$112K	﹤0.01%	2724
2020 Q1	$268K	Buy	3,015 +700	+30%	+$83.4K	﹤0.01%	2673
2019 Q4	$264K	Hold	2,315	–	–	﹤0.01%	2823
2019 Q3	$143K	Hold	2,315	–	–	﹤0.01%	3018
2019 Q2	$181K	Buy	2,315 +795	+52%	+$90.2K	﹤0.01%	2992
2019 Q1	$205K	Hold	1,520	–	–	﹤0.01%	2900
2018 Q4	$122K	Hold	1,520	–	–	﹤0.01%	2971
2018 Q3	$160K	Hold	1,520	–	–	﹤0.01%	3025
2018 Q2	$152K	Buy	1,520 +105	+7%	+$11.9K	﹤0.01%	3014
2018 Q1	$178K	Hold	1,415	–	–	﹤0.01%	2880
2017 Q4	$236K	Buy	1,415 +285	+25%	+$73K	﹤0.01%	2810
2017 Q3	$356K	Sell	1,130 -1,896	-63%	-$598K	﹤0.01%	2696
2017 Q2	$899K	Buy	+3,026	New	+$809K	﹤0.01%	2344
2015 Q2	–	Sell	-205	Closed	-$67K	–	3343
2015 Q1	$67K	Buy	+205	New	+$72.9K	﹤0.01%	3093

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's CALA Position: Q2 2021 in Review

AllianceBernstein sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 3,960 shares — an estimated $192K sold.

AllianceBernstein first reported a position in CALA in Q1 2015 and held it in 17 quarters. The position peaked at $899K in Q2 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

AllianceBernstein reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
AllianceBernstein sold 3,960 Calithera Biosciences, Inc shares in Q2 2021, an estimated $192K.
AllianceBernstein first reported a position in Calithera Biosciences, Inc in Q1 2015 and held it in 17 quarters.
AllianceBernstein's Calithera Biosciences, Inc position peaked at $899K in Q2 2017.
76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.